Estrogen use in postmenopausal women.
Fifteen per cent of postmenopausal women living in a retirement community used oral estrogens. Both use and new-use continued in the seventh, eighth and ninth decades of life, although use and age-specific use-prevalence declined after age 70. Mean duration of most recent continuous use was 105 months. Vaginal estrogenic preparations were used infrequently, briefly, and usually by women who also used oral estrogens in the same year. The most commonly used oral estrogenic preparation was conjugated equine estrogens (Premarin).
D000284:Administration, Oral; D000368:Aged; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use*; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008593:Menopause; D008875:Middle Aged; D014621:Vagina
D004967:Estrogens; D004966:Estrogens, Conjugated (USP)